Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by NYU Langone Health is investigating ketamine to reduce chronic postsurgical pain; the study is currently listed as active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: NYU Langone Health | Conditions: Chronic Postsurgical Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING